Status:
COMPLETED
Developing a Exercise Program for Patients Undergoing Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Chimei Medical Center
Conditions:
Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
20+ years
Brief Summary
Background: Hematopoietic stem cell transplantation (HSCT) is a highly aggressive treatment, which is associated with numerous treatment-related side effects, such as fatigue and decreased functional ...
Eligibility Criteria
Inclusion
- First-time hematopoietic stem cell transplantation (HSCT) patients who are ambulatory, their primary caregivers, and physical therapists and nurses participating in the exercise intervention;
- Age 20 years or older;
- Capable of understanding and complying with the study objectives;
- No psychiatric disorders or cognitive impairments.
Exclusion
- HSCT patients deemed unsuitable for exercise participation based on the attending physician's assessment;
- HSCT patients at risk of fractures or confined to bed rest due to musculoskeletal conditions.
Key Trial Info
Start Date :
February 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 13 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06907004
Start Date
February 14 2023
End Date
October 13 2023
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chimei Medical Center
Tainan, Taiwan, Taiwan, 71004